MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer
Sung‐Hsin Kuo, Ming‐Feng Wei, Yi‐Hsuan Lee, Jui-Chueh Lin, Wen-Chi Yang, Shi‐Yi Yang, Chiun‐Sheng Huang
Topics & Concepts
Breast cancerCancer researchCyclin D1MedicineCancerMAPK/ERK pathwayCell growthCell cycleInternal medicineEndocrinologyBiologyOncologySignal transductionCell biologyGeneticsMelanoma and MAPK PathwaysCancer Mechanisms and TherapyNF-κB Signaling Pathways